Cesca Therapeutics Announces First Quarter 2018 Financial Results and Provides Corporate Update Genetics Investing
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018 Medical Device Investing
3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma Pharmaceutical Investing
Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress Genetics Investing
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology Genetics Investing
